Corrigendum to "Discontinuation of BRAF/MEK inhibitor therapy after long-lasting response: Clinical outcomes in advanced melanoma" [Eur J Cancer 234 (2026) 116200].
Saved in:
| Title: | Corrigendum to "Discontinuation of BRAF/MEK inhibitor therapy after long-lasting response: Clinical outcomes in advanced melanoma" [Eur J Cancer 234 (2026) 116200]. |
|---|---|
| Authors: | Døssing, Rasmus Haunstrup1 (AUTHOR), Hesselberg, Elisabeth2 (AUTHOR), Clausen, Anna Burton3 (AUTHOR), Luczak, Adam Andrzej4 (AUTHOR), Presti, Mario1 (AUTHOR), Svane, Inge Marie1 (AUTHOR), Schmidt, Henrik2 (AUTHOR), Bastholt, Lars3 (AUTHOR), Donia, Marco1 (AUTHOR), Ellebaek, Eva1 (AUTHOR) eva.ellebaek.steensgaard@regionh.dk |
| Source: | European Journal of Cancer. Jun2026, Vol. 242, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
